BIOADHESIVE OPHTHALMICS
Bioadhesive Ophthalmics is a developer of a pharmaceutical platform that aims to transform ophthalmology by relieving patients from the burden of their eye diseases. The company's pharmaceutical technology includes a mucoadhesive ocular hydrogel insert that releases a therapeutic molecule medicinal substances to the eye continuously over a period of a week, thus enhancing the impact of treatment, enabling the eye patients to get ease from the complexity of frequent eye drop application by generating a continuous and controlled sustained hydrogel release. It was founded in Orsay, Ile-de-France, France by Jean Garrec and Jean Cuiné in 2020.
BIOADHESIVE OPHTHALMICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Orsay, Ile-de-France, France
Country:
France
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
KelSie Biotech
KelSie Biotech develops high bioavailability delivery methods to formulate and deliver sensitive active pharmaceutical ingredients.
Current Employees Featured
Jean Cuiné Co-Founder & Chief Technical Officer @ Bioadhesive Ophthalmics
Co-Founder & Chief Technical Officer
2019-01-01
Jean Garrec Co-Founder & Chief Executive Officer @ Bioadhesive Ophthalmics
Co-Founder & Chief Executive Officer
2020-01-01
Founder
Investors List
AGORANOV
AGORANOV investment in Non Equity Assistance - Bioadhesive Ophthalmics
More informations about "Bioadhesive Ophthalmics"
Biophta – New Standard of Care for Eye Diseases
Founded in 2020 by two entrepreneurs with a track record in the development of ophthalmic therapies, BIOPHTA aims to radically improve the efficacy of eye treatments by leveraging the …See details»
Bioadhesive Ophthalmics - Crunchbase Company …
Bioadhesive Ophthalmics is a developer of a pharmaceutical platform that aims to transform ophthalmology by relieving patients from the burden of their eye …See details»
BIOPHTA - LinkedIn
BIOPHTA | 2,438 followers on LinkedIn. Changing the lives of patients suffering from chronic eye diseases ! | World Health Organization evaluates between 200 and 300 million, the number of people ...See details»
Bioadhesive Ophthalmics - Products, Competitors, Financials, …
About Bioadhesive Ophthalmics. Bioadhesive Ophthalmics transforms ophthalmology by improving the efficacy and potency of eye medications. The firm's innovation is a …See details»
BIOADHESIVE OPHTHALMICS Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BIOADHESIVE OPHTHALMICS of RENNES, BRETAGNE. Get the latest business insights …See details»
BIOADHESIVE OPHTHALMICS - Societe.com
BIOADHESIVE OPHTHALMICS, société par actions simplifiée, au capital social de 49166,30 EURO, dont le siège social est situé au 6 BOULEVARD DUBREUIL, 91400 ORSAY, …See details»
Bioadhesive Ophthalmics - Headquarter Location, Corporate Office ...
Bioadhesive Ophthalmics is Pharmaceuticals in France that focus on pharmaceutical technology business. Founded in 2020. They cover business area such as developer, ophthalmology, …See details»
BIOADHESIVE OPHTHALMICS | Paris, France Startup
BIOADHESIVE OPHTHALMICS Transformer l'Ophtalmologie grâce à une plateforme biopolymères mucoadhésifs pouvant libérer une molécule thérapeutique en continu à l’œil durant une semaine. Stage Product In …See details»
Société BIOADHESIVE OPHTHALMICS : Chiffre d'affaires ... - Pappers
Apr 21, 2025 Les déclarations de comptes de BIOADHESIVE OPHTHALMICS nous permettent de déduire que son chiffre d'affaires était inférieur à 700 000 € ou que son bilan était inférieur …See details»
Technology - Biophta
Once applied, BIOPHTA’s ophthalmic insert transforms into a hydrogel pellet that stays in place on the eye without moving, and delivers a continuous and controlled low dose of drug for 7 days. It’s the first time a therapy has such …See details»
Topical Bioadhesive Ocular Insert
Our new non-invasive topical ocular insert is aimed at several ophthalmic indications by allowing more effective treatments and better control of diseases. Two formulations using generic molecules will be initially evaluated at the …See details»
Carbohydrate polymer-based bioadhesive formulations and their ...
Jul 1, 2023 In the past decades, carbohydrate polymer-based ocular formulations have attracted much attention due to the biocompatibility, biodegradability, and bioadhesive features of these …See details»
Bioadhesive Ophthalmics - Funding, Financials, Valuation & Investors
Mar 1, 2020 Bioadhesive Ophthalmics aims to transform ophthalmology by relieving patients from the burden of their eye diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Bioadhesive Ophthalmics - Crunchbase
Organization. Bioadhesive Ophthalmics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies …See details»
Bioadhesives in Ocular Drug Delivery | 9 | Biopharmaceutics of …
Bioadhesive polymers have generated considerable interest as a way to substantially improve the performance of controlled delivery systems. This chapter focuses on a relatively new way to …See details»
Biophta lève 6,5 M€ pour traiter les maladies de l’oeil - PoleSocietes
Jun 28, 2024 BIOADHESIVE OPHTHALMICS. Recherche-développement en autres sciences physiques et naturelles. Voir l'entreprise Documents. Sommaire. Un traitement totalement …See details»
Bioadhesive Ophthalmics - Tech Stack, Apps, Patents & Trademarks
Bioadhesive Ophthalmics aims to transform ophthalmology by relieving patients from the burden of their eye diseases.See details»
Bioadhesive Ophthalmics - Contacts, Employees, Board Members, …
Organization. Bioadhesive Ophthalmics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Bioadhesive Ophthalmics - Updates, News, Events, Signals
Bioadhesive Ophthalmics aims to transform ophthalmology by relieving patients from the burden of their eye diseases.See details»
Full article: Thyroid Eye disease in the Biologic Era: a 40-year ...
2 days ago The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or …See details»